MedPath

江苏天晟药业股份有限公司

Ownership
-
Established
2001-04-09
Employees
-
Market Cap
-
Website
https://www.jstsyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:6

Drug Approvals

Monoammonium Glycyrrhizinate S

Product Name
甘草酸单铵盐S
Approval Number
国药准字H20057930
Approval Date
Aug 13, 2020
NMPA

Oxymatrine

Product Name
苦参素
Approval Number
国药准字H20044403
Approval Date
Aug 13, 2020
NMPA

Matrine

Product Name
苦参碱
Approval Number
国药准字H20046658
Approval Date
Aug 13, 2020
NMPA

Puerarin

Product Name
葛根素
Approval Number
国药准字H20044253
Approval Date
Aug 13, 2020
NMPA

Potassium Glycyrrhefate M

Product Name
甘草酸单钾M
Approval Number
国药准字H20057335
Approval Date
Aug 13, 2020
NMPA

Diammonium Glycyrrhizinate

Product Name
甘草酸二铵
Approval Number
国药准字H20073708
Approval Date
Sep 19, 2017
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.